首页> British journal of cancer> Clinical and genomic analysis of a randomised phase II study evaluating anastrozole and fulvestrant in postmenopausal patients treated for large operable or locally advanced hormone-receptor-positive breast cancer.

Clinical and genomic analysis of a randomised phase II study evaluating anastrozole and fulvestrant in postmenopausal patients treated for large operable or locally advanced hormone-receptor-positive breast cancer.

导出 OA

翻译打印收藏纠错

第一作者： Nathalie,Quenel-Tueux

第一单位： Institut Bergonié Comprehensive Cancer Centre, 229 Cours de l'Argonne, F-33000 Bordeaux, France.

作者： Nathalie,Quenel-Tueux ^[1] ; Marc,Debled ^[1] ; Justine,Rudewicz ^[2] ; Gaetan,MacGrogan ^[3] ; Marina,Pulido ^[4] ; Louis,Mauriac ^[1] ; Florence,Dalenc ^[5] ; Thomas,Bachelot ^[6] ; Barbara,Lortal ^[1] ; Christelle,Breton-Callu ^[1] ; Nicolas,Madranges ^[1] ; Christine Tunon,de Lara ^[1] ; Marion,Fournier ^[1] ; Hervé,Bonnefoi ^[3] ; Hayssam,Soueidan ^[7] ; Macha,Nikolski ^[8] ; Audrey,Gros ^[3] ; Catherine,Daly ^[9] ; Henry,Wood ^[9] ; Pamela,Rabbitts ^[9] ; Richard,Iggo ^[3]

作者单位： Institut Bergonié Comprehensive Cancer Centre, 229 Cours de l'Argonne, F-33000 Bordeaux, France. ^[1] 1] Institut Bergonié Comprehensive Cancer Centre, 229 Cours de l'Argonne, F-33000 Bordeaux, France [2] INSERM U916, 229 Cours de l'Argonne, F-33000 Bordeaux, France [3] University Bordeaux, 16 Avenue Léon Duguit, F-33608 Pessac, France [4] Bordeaux Bioinformatics Centre, University Bordeaux, 146, rue Léo Saignat, F-33076 Bordeaux, France [5] CNRS UMR5800, Bordeaux Computer Science Lab, 351 Cours de la Libération, F-33405 Talence, France. ^[2] 1] Institut Bergonié Comprehensive Cancer Centre, 229 Cours de l'Argonne, F-33000 Bordeaux, France [2] INSERM U916, 229 Cours de l'Argonne, F-33000 Bordeaux, France [3] University Bordeaux, 16 Avenue Léon Duguit, F-33608 Pessac, France. ^[3] 1] Inserm Clinical Investigation Centre CIC1401, Epidemiological Unit, 229 Cours de l'Argonne, Bordeaux 33076, France [2] Clinical and Epidemiological Research Unit, Institut Bergonie, 229 Cours de l'Argonne, Bordeaux 33076, France. ^[4] Institut Claudius Regaud, IUCT-Oncopole Toulouse, 1 Avenue Irène Joliot-Curie, F-31059 Toulouse, France. ^[5] CLCC Lyon, 28 Promenade Léa et Napoléon Bullukian, F-69008 Lyon, France. ^[6] Bordeaux Bioinformatics Centre, University Bordeaux, 146, rue Léo Saignat, F-33076 Bordeaux, France. ^[7] 1] University Bordeaux, 16 Avenue Léon Duguit, F-33608 Pessac, France [2] Bordeaux Bioinformatics Centre, University Bordeaux, 146, rue Léo Saignat, F-33076 Bordeaux, France [3] CNRS UMR5800, Bordeaux Computer Science Lab, 351 Cours de la Libération, F-33405 Talence, France. ^[8] Leeds Institute of Cancer and Pathology, University of Leeds, Beckett Street, Leeds LS9 7TF, UK. ^[9]